Form 4 for BAX Baxter International
Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-03 · accession 0001062993-22-011693 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-05 | 2022-05-03 | BAX | Wendell Amy McBride | Dir | A - Grant | $0.00 | +2,706 | 13.2K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $1 par value | 2022-05-03 | A | A | 2,706 | $0.00 | 13,168 | D | — | — | (F1) The reporting person received a grant of fully vested shares of common stock of Baxter International Inc. (BII), subject to the terms and conditions of the applicable grant. (F2) The amount of securities beneficially owned include 42.90 shares acquired under the BII Dividend Reinvestment Plan (DRIP) between April 1, 2019 and April 1, 2021. |